» Articles » PMID: 31481664

PIK3CA Mutations in Lipomatosis of Nerve with or Without Nerve Territory Overgrowth

Overview
Journal Mod Pathol
Specialty Pathology
Date 2019 Sep 5
PMID 31481664
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Lipomatosis of nerve is a rare malformation characterized by a fibrolipomatous proliferation within peripheral nerve. Lipomatosis of nerve most frequently involves the median nerve, and manifests clinically as a compressive neuropathy. However, 30-60% of cases are associated with tissue overgrowth within the affected nerve's territory (e.g., macrodactyly for lipomatosis of nerve in the distal median nerve). Somatic activating PIK3CA mutations have been identified in peripheral nerve from patients with lipomatosis of nerve with type I macrodactyly, which is now classified as a PIK3CA-related overgrowth spectrum disorder. However, the PIK3CA mutation status of histologically confirmed lipomatosis of nerve, including cases involving proximal nerves, and cases without territory overgrowth, has not been determined. Fourteen histologically confirmed cases of lipomatosis of nerve involving the median (N = 6), brachial plexus (N = 1), ulnar (N = 3), plantar (N = 2), sciatic and superficial peroneal nerves (N = 1 each) were included. Ten cases had nerve territory overgrowth, ranging from macrodactyly to hemihypertrophy; and four cases had no territory overgrowth. Exome sequencing revealed "hotspot" activating PIK3CA missense mutations in 6/7 cases. Droplet digital polymerase chain reaction for the five most common PIK3CA mutations (p.H1047R, p.H1047L, p.E545K, p.E542K, and p.C420R) confirmed the exome results and identified an additional six cases with mutations (12/14 total). PIK3CA mutations were found in 8/10 cases with territory overgrowth (N = 7 p.H1047R and N = 1 p.E545K), including two proximal nerve cases with extremity overgrowth, and 4/4 cases without territory overgrowth (p.H1047R and p.H1047L, N = 2 each). The variant allele frequency of PIK3CA mutations (6-32%) did not correlate with the overgrowth phenotype. Three intraneural lipomas had no detected PIK3CA mutations. As PIK3CA mutations are frequent events in lipomatosis of nerve, irrespective of anatomic site or territory overgrowth, we propose that all phenotypic variants of this entity be classified within the PIK3CA-related overgrowth spectrum and termed "PIK3CA-related lipomatosis of nerve".

Citing Articles

When, where and which PIK3CA mutations are pathogenic in congenital disorders.

Angulo-Urarte A, Graupera M Nat Cardiovasc Res. 2024; 1(8):700-714.

PMID: 39196083 DOI: 10.1038/s44161-022-00107-8.


Clinical characteristics and surgical management of facial infiltrating lipomatosis: a single center experience.

Chen H, Sun B, Xia W, Qiu Y, Gao W, Hua C Head Face Med. 2024; 20(1):13.

PMID: 38378686 PMC: 10877823. DOI: 10.1186/s13005-024-00412-6.


Test yourself: chest wall asymmetry.

Olisa C, Pressney I, ODonnell P Skeletal Radiol. 2024; 53(8):1657-1659.

PMID: 38240756 DOI: 10.1007/s00256-024-04573-y.


Unrecognized sciatic lipomatosis of the nerve diagnosed by telehealth: illustrative case.

Marek T, Spinner N, Spinner R J Neurosurg Case Lessons. 2024; 7(3).

PMID: 38224590 PMC: 10791550. DOI: 10.3171/CASE23609.


Targeted next-generation sequencing for detection of PIK3CA mutations in archival tissues from patients with Klippel-Trenaunay syndrome in an Asian population : List the full names and institutional addresses for all authors.

Sasaki Y, Ishikawa K, Hatanaka K, Oyamada Y, Sakuhara Y, Shimizu T Orphanet J Rare Dis. 2023; 18(1):270.

PMID: 37667289 PMC: 10478188. DOI: 10.1186/s13023-023-02893-1.


References
1.
Bisceglia M, Vigilante E, Ben-Dor D . Neural lipofibromatous hamartoma: a report of two cases and review of the literature. Adv Anat Pathol. 2007; 14(1):46-52. DOI: 10.1097/PAP.0b013e31802f04b7. View

2.
Silverman T, ENZINGER F . Fibrolipomatous hamartoma of nerve. A clinicopathologic analysis of 26 cases. Am J Surg Pathol. 1985; 9(1):7-14. DOI: 10.1097/00000478-198501000-00004. View

3.
Plaza J, Kazakov D, Casas G, Requena L, Sanmartin O, Kacerovska D . Fibrolipomatous hamartoma of the nerve: a clinicopathologic report of 13 cases. J Am Acad Dermatol. 2014; 70(4):736-742. DOI: 10.1016/j.jaad.2013.10.002. View

4.
Mahan M, Niederhauser B, Amrami K, Spinner R . Long-term progression of lipomatosis of nerve. World Neurosurg. 2013; 82(3-4):492-9. DOI: 10.1016/j.wneu.2013.09.005. View

5.
Tahiri Y, Xu L, Kanevsky J, Luc M . Lipofibromatous hamartoma of the median nerve: a comprehensive review and systematic approach to evaluation, diagnosis, and treatment. J Hand Surg Am. 2013; 38(10):2055-67. DOI: 10.1016/j.jhsa.2013.03.022. View